Market capitalization | €14.61b |
Enterprise Value | €19.80b |
PER (TTM) P/E ratio | 97.40 |
EV/FCF (TTM) EV/FCF | 553.04 |
EV/Sales (TTM) EV/Sales | 5.98 |
P/S ratio (TTM) P/S ratio | 4.41 |
P/B ratio (TTM) P/B ratio | 5.42 |
Dividend yield | 0.35% |
Last dividend (FY23) | €0.74 |
Activate alerts on the share price, dividend yield, valuation (e.g. P/E ratio or EV/sales) or strategy scores and sit back and relax.
20 Analysts have issued a Sartorius AG forecast:
20 Analysts have issued a Sartorius AG forecast:
Mar '24 |
+/-
%
|
||
Turnover | 3,312 3,312 |
18%
18%
|
|
Gross income | 1,494 1,494 |
30%
30%
|
|
EBITDA | 940 940 |
36%
36%
|
EBIT (operating result) EBIT | 576 576 |
51%
51%
|
Net profit | 149 149 |
74%
74%
|
Figures in millions EUR.
If you wish, you can receive an e-mail every morning in time for breakfast containing all the stock news relevant to you.
Sartorius AG is an international laboratory and process technology provider for the biotech, pharmaceutical, and food industries. It operates through the Bioprocess Solutions and Lab Products and Services divisions. The Bioprocess Solutions division focuses on the major areas of activity of filtration, fluid management, fermentation, and purification. The Lab Products and Services division focuses on lab balances, pipettes, and laboratory water purification systems. The company was founded by Florence Sartorius, Sr. in 1870 and is headquartered in Goettingen, Germany.
Head office | Germany |
CEO | Joachim Kreuzburg |
Employees | 14,614 |
Founded | 1870 |
Website | www.sartorius.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.